We observed that there was a positive association trend between neoantigen loads and both T cell CD8+ and CD4+ memory-activated types in all cancer types except thyroid and kidney (Binomial test P = 0.11 and P = 0.02 for T cell CD8+ and CD4+ memory-activated types, respectively). This evidence concerns the gene CD8A and cancer.